Pharmaceutical formulations: salts of 8-[{1-(3,5-bis-(trifluoromethyl)phenyl)-ethoxy}-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one and treatment methods using the same
Pharmaceutical formulations containing salts of (5S,8S)-8-[{(1 R)-1- (3,5-Bis-trifluoromethyl)phenyl]-ethoxy}-methyl]-8-phenyl-1,7- diazaspiro[4.5]decan-2-one, represented by Formula I, are disclosed. Disclosed also are methods of treatment utilizing such dosage forms.